Compare EHang Holdings Ltd - ADR (EH) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EHang Holdings Ltd - ADR vs GeneDx Holdings Corp — how do they compare? EHang Holdings Ltd - ADR trades at $5.69 (market cap $437.63M), while GeneDx Holdings Corp trades at $81.93 (market cap $2.44B). The key difference: GeneDx Holdings Corp is far larger — about 5.6× EHang Holdings Ltd - ADR's market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, EHang Holdings Ltd - ADR nearer its low. Which is the better fit depends on your goals.
| EH | WGS | |
|---|---|---|
Market Cap | $437.63M | $2.44B |
Sector | Industrials | Technology |
52-Week High | $19.44 | $167.51 |
52-Week Low | $4.90 | $34.51 |
Enterprise Value | $376.84M | $2.48B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EHang Holdings (EH) trades at $5.66, down 0.53% on the day, with a mixed technical outlook showing a bullish overall signal but bearish moving averages. The company reported Q1 2026 revenue of $418 million, but net losses persist with a margin of -77.57%. Recent news includes the successful pilotless eVTOL flight in Kazakhstan, highlighting operational progress amid financial challenges.
The stock presents high-risk potential with analyst consensus divided and a price target of $6.97. Investment appeal hinges on commercialization success and cost management, but substantial losses and competitive pressures pose significant risks to near-term shareholder value.
GeneDx Holdings Corp (WGS) trades at $82.07, up 5.38% in the past 24 hours, with technical indicators showing a bullish trend. The stock beat Q2 2026 EPS estimates but reported negative net income margins. Recent news highlights product expansion and institutional buying interest, though class-action lawsuits pose near-term sentiment risks.
Outlook is mixed: strong analyst buy ratings (90.9%) and a $79.25 consensus target suggest upside, but high valuation multiples and persistent losses require caution. Key risks include profitability challenges and legal overhangs, while revenue growth and market positioning offer long-term potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About EHang Holdings Ltd - ADR
EHang Holdings Ltd is an autonomous aerial vehicle (AAV) technology platform company. It focuses on making safe, autonomous and eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with AAV products and commercial solutions: air mobility (including passenger transportation and logistics), smart city management and aerial media solutions. As the forerunner of cutting-edge AAV technologies and commercial solutions in the global Urban Air Mobility industry, it continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
Read more on EH →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
